<DOC>
	<DOCNO>NCT00883649</DOCNO>
	<brief_summary>The purpose study determine effectiveness nutritional supplement post-menopausal woman age 40 old moderate severe dry eye . This study conduct determine sign symptom dry eye improve use nutritional supplement .</brief_summary>
	<brief_title>Efficacy Safety Study Nutritional Supplements Treatments Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Signature write informed consent form Patient motivation willingness cooperate investigator follow required medication regimen Patient willingness ability return visit study Rapid tear film break time eight second less least one eye AND/OR Signs meibomian gland dysfunction ( MGD ) include least grade one lid notching , presence orifice pustule At least grade one fluorescein superficial punctate keratitis ( SPK ) least one corneal quadrant least grade one conjunctival lissamine green stain least one eye . Ocular Surface Disease Index score sixteen great . Willing discontinue use current dry eye treatment ( except artificial tear ) four week prior randomization , course six month study Postmenopausal woman age 40 year old . Post menopause define absence menstrual period least one year , surgical hysterectomy bilateral oophorectomy less six month prior If use transdermal , vaginal systemic estrogen , progesterone , estrogen derivative , must stable dose least 90 day , plan stay stable dose duration study Concurrent involvement clinical trial involve investigational drug device Compromised cognitive ability may expect interfere study compliance Uncontrolled poorly control systemic disease ( e.g. , hypertension , diabetes ) presence significant illness ( e.g. , serious gastrointestinal , renal , hepatic , endocrine , pulmonary , cardiac , neurological disease , cancer , AIDS , cerebral dysfunction ) could , judgment investigator , jeopardize subject safety interfere interpretation result study Known hypersensitivity component study procedural medication Anticipated contact lens wear study History corneal transplant Active ocular infection , uveitis nonKCS inflammation History recurrent herpes keratitis active disease within last six month History cataract surgery within 3 month prior enrollment History ocular surface surgery ( i.e . refractive , lasik , pterygium ) within 6 month prior enrollment corneal disorder abnormality affect corneal sensitivity normal spread tear film [ except superficial punctate keratitis ( SPK ) ] Use systemic cyclosporine within prior 3 month Initiation , discontinuation change dosage antihistamine , cholinergic agent , betablocking agent , tricyclic SSRI antidepressant , phenothiazine , topical systemic acne rosacea medication two month prior enrollment , anticipated change dosage course study Topical ophthalmic medication within prior 4 week , anticipate use study ( except artificial tear ) Use Coumadin Plavix within prior 2 week , anticipate use study . Stable dose aspirin 325mg 85 mg per day permit . Use fish oil , borage , even primrose , flaxseed black current seed oil supplement past three month Routine , usual dietary intake 12 ounce cold water fatty fish ( tuna , salmon , mackerel , sea bass , sardine herring ) per week Occlusion lacrimal puncta either surgically temporary collagen punctal plug within one month prior study , anticipate use study A patient condition situation , judgment investigator , may put patient significant risk , may confound study result , may interfere patient 's participation study</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Keratoconjunctivitis Sicca</keyword>
	<keyword>Dry Eyes</keyword>
	<keyword>Post-menopausal</keyword>
</DOC>